Lowell Blake & Associates Inc. Edwards Lifesciences Corp Transaction History

Lowell Blake & Associates Inc.

$1.4 Billion
Q3 2023

A detailed history of Lowell Blake & Associates Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lowell Blake & Associates Inc. holds 143,242 shares of EW stock, worth $10.6 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

143,242

Previous 130,121 10.08%

Holding current value

$10.6 Million

Previous $12.3 Million 19.15%

% of portfolio

0.71%

Previous 3.56%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $909,022 - $1.23 Million	13,121 Added 10.08%	143,242 $9.92 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $88,004 - $101,970	-1,081 Reduced 0.82%	130,121 $12.3 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $25,545 - $29,071	-344 Reduced 0.26%	131,202 $10.9 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $1.57 Million - $2.01 Million	22,979 Added 21.17%	131,546 $9.81 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $645,286 - $840,509	7,834 Added 7.78%	108,567 $8.97 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $1.94 Million - $2.88 Million	22,416 Added 28.62%	100,733 $9.58 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $1.06 Million - $1.34 Million	10,437 Added 15.38%	78,317 $9.22 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $699,808 - $859,743	6,579 Added 10.73%	67,880 $8.79 Million
Q3 2021 Oct 15, 2021	SELL	$102.91 - $122.75 $135,944 - $162,152	-1,321 Reduced 2.11%	61,301 $6.94 Million
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $140,767 - $175,892	-1,679 Reduced 2.61%	62,622 $6.49 Million
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $1.44 Million - $1.66 Million	18,329 Added 39.87%	64,301 $5.38 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $98,717 - $125,623	1,377 Added 3.09%	45,972 $4.19 Million
Q3 2020 Oct 22, 2020	BUY	$67.19 - $87.44 $374,248 - $487,040	5,570 Added 14.27%	44,595 $3.56 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.63 Million - $2.18 Million	28,307 Added 264.11%	39,025 $2.7 Million
Q1 2020 Jul 01, 2020	BUY	$52.41 - $81.0 $128,509 - $198,612	2,452 Added 29.66%	10,718 $2.02 Million
Q4 2019 Jul 01, 2020	BUY	$71.7 - $82.09 $592,672 - $678,555	8,266 New	8,266 $1.93 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowell Blake & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lowell Blake & Associates Inc. with notifications on news.

Account

Lowell Blake & Associates Inc. Edwards Lifesciences Corp Transaction History